These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21436070)

  • 21. HIV controllers are distinguished by chemokine expression profile and HIV-specific T-cell proliferative potential.
    Card CM; Keynan Y; Lajoie J; Bell CP; Dawood M; Becker M; Kasper K; Fowke KR
    J Acquir Immune Defic Syndr; 2012 Apr; 59(5):427-37. PubMed ID: 22240463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors related to loss of HIV-specific cytotoxic T lymphocyte activity.
    Gamberg J; Barrett L; Bowmer MI; Howley C; Grant M
    AIDS; 2004 Mar; 18(4):597-604. PubMed ID: 15090764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-year clinical and immune outcomes in human immunodeficiency virus-infected children who reconstitute CD4 T cells without control of viral replication after combination antiretroviral therapy.
    Ghaffari G; Passalacqua DJ; Caicedo JL; Goodenow MM; Sleasman JW
    Pediatrics; 2004 Nov; 114(5):e604-11. PubMed ID: 15492356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.
    Berges BK; Wheat WH; Palmer BE; Connick E; Akkina R
    Retrovirology; 2006 Nov; 3():76. PubMed ID: 17078891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL-2 administration.
    Porcellini S; Vallanti G; Nozza S; Poli G; Lazzarin A; Tambussi G; Siccardi AG; Grassi F
    AIDS; 2003 Jul; 17(11):1621-30. PubMed ID: 12853744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of HIV-1 in Affecting the Proliferation Ability of HPCs Derived From BM.
    Guo X; He S; Lv X; Ding H; Li S; Kang J; Liu J; Qin C; Geng W; Jiang Y; Shang H
    J Acquir Immune Defic Syndr; 2016 Apr; 71(5):467-73. PubMed ID: 26974413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High thymic volume is associated with viral replication and immunologic impairment only early after HAART interruption in chronic HIV infection.
    Vallejo A; Valladares A; De Felipe B; Vivancos J; Gutierrez S; Soriano-Sarabia N; Ruiz-Mateos E; Lissen E; Leal M
    Viral Immunol; 2005; 18(4):740-6. PubMed ID: 16359240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia.
    Karlsson AC; Younger SR; Martin JN; Grossman Z; Sinclair E; Hunt PW; Hagos E; Nixon DF; Deeks SG
    AIDS; 2004 Apr; 18(7):981-9. PubMed ID: 15096800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.
    Hunt PW; Martin JN; Sinclair E; Bredt B; Hagos E; Lampiris H; Deeks SG
    J Infect Dis; 2003 May; 187(10):1534-43. PubMed ID: 12721933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic function and virologic suppression among children with perinatally acquired HIV Infection on highly active antiretroviral therapy.
    Rutstein RM; Gebo KA; Flynn PM; Fleishman JA; Sharp VL; Siberry GK; Spector SA
    Med Care; 2005 Sep; 43(9 Suppl):III15-22. PubMed ID: 16116305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent HIV-1 replication does not explain low levels of T-cell interferon-gamma mRNA and elevated serum NO(2) (-)/NO(3) (-) in patients with stable CD4 T-cell responses to HAART.
    Lee S; Almeida CA; French MA; Price P
    Clin Exp Immunol; 2004 Oct; 138(1):110-5. PubMed ID: 15373912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
    Persaud D; Pierson T; Ruff C; Finzi D; Chadwick KR; Margolick JB; Ruff A; Hutton N; Ray S; Siliciano RF
    J Clin Invest; 2000 Apr; 105(7):995-1003. PubMed ID: 10749578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of suppression of viral replication by highly active antiretroviral therapy on immune function and phenotype in chronic HIV-1 infection.
    Lange CG; Lederman MM; Madero JS; Medvik K; Asaad R; Pacheko C; Carranza C; Valdez H
    J Acquir Immune Defic Syndr; 2002 May; 30(1):33-40. PubMed ID: 12048361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression.
    Claiborne DT; Prince JL; Scully E; Macharia G; Micci L; Lawson B; Kopycinski J; Deymier MJ; Vanderford TH; Nganou-Makamdop K; Ende Z; Brooks K; Tang J; Yu T; Lakhi S; Kilembe W; Silvestri G; Douek D; Goepfert PA; Price MA; Allen SA; Paiardini M; Altfeld M; Gilmour J; Hunter E
    Proc Natl Acad Sci U S A; 2015 Mar; 112(12):E1480-9. PubMed ID: 25730868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection.
    Barbour JD; Hecht FM; Wrin T; Segal MR; Ramstead CA; Liegler TJ; Busch MP; Petropoulos CJ; Hellmann NS; Kahn JO; Grant RM
    J Infect Dis; 2004 Jul; 190(2):251-6. PubMed ID: 15216458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients.
    Witwer KW; Watson AK; Blankson JN; Clements JE
    Retrovirology; 2012 Jan; 9():5. PubMed ID: 22240256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel 8-color flow cytometry panel to study activation, maturation and senescence of CD4 and CD8 T lymphocytes in HIV-infected individuals at different stages of disease.
    Bordoni V; Casetti R; Capuano G; De Stefani B; Piselli P; Gioia C; Agrati C; Martini F
    Int J Immunopathol Pharmacol; 2012; 25(2):415-24. PubMed ID: 22697073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
    Benito JM; López M; Lozano S; Ballesteros C; Martinez P; González-Lahoz J; Soriano V
    J Acquir Immune Defic Syndr; 2005 Apr; 38(4):373-81. PubMed ID: 15764953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poor functional immune recovery in aged HIV-1-infected patients following successfully treatment with antiretroviral therapy.
    Kasahara TM; Hygino J; Andrade RM; Monteiro C; Sacramento PM; Andrade AF; Bento CA
    Hum Immunol; 2015 Oct; 76(10):701-10. PubMed ID: 26429325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
    Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
    Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.